Alkem Laboratories Ltd had earlier announced that US FDA has issued an Establishment Inspection Report (EIR) for the Company's manufacturing facility located at St. Louis, USA which was inspected from 12th March, 2018 to 16th March, 2018.
In response to the Form 483 issued by the US FDA containing one observation, the Company had submitted a detailed corrective and preventive action (CAPA) plan to the regulator within the stipulated timelines. The inspection has now been closed by the US FDA.
Shares of Alkem Laboratories Ltd was last trading in BSE at Rs.1900 as compared to the previous close of Rs. 1900.3. The total number of shares traded during the day was 7934 in over 533 trades.
The stock hit an intraday high of Rs. 1950 and intraday low of 1899. The net turnover during the day was Rs. 15159076.